Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics, safety, and efficacy of P03277 in pediatric patients undergoing CNS contrast-enhanced MRI completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Conditions in Pediatric Patients
• Central Nervous System Disorders

Drugs mentioned

• P03277

Snippet

Sponsor: Guerbet | Conditions: Central Nervous System Indication, Pediatric Patients | Phase 2 | Status: COMPLETED | Results posted: 2022-06-01